Published Date : Nov 28, 2016
ALBANY, NY, Nov 28, 2016: The report offers a comprehensive study of the market’s current status and estimates the future by analyzing several drivers and restraints that are expected to impact the regional and global market for central vascular access devices.
The overview section of the 173-page market intelligence study explores that vascular access devices have been used by medical practitioners for over four decades. These devices, also known as catheters, allow medications to be delivered directly into the veins, can remain attached to the patients for longer periods (weeks, months or even longer), and are less likely to clot. The central vascular access devices are intended for patients suffering from acute chronic diseases, which require catheters that can remain within a patient’s venous system comfortably for a considerable period of time. With technological advancements leading to robust and safe vascular access devices, the global market for the same is projected for a healthy growth rate during the forecast period of 2012 to 2022.
Several factors are driving the global market for vascular access devices. For example, the vast global population and the rising number of geriatrics, increasing financial power of developing countries, the growing burden of chronic conditions, nurse-led peripherally inserted central catheter placement, central vascular catheter placement protocols, technological advancements in the field, and the introduction of interventional radiology. The report also studies some of the factors that may hinder the growth of the market during the forecast period. These include safety concerns among the patients, product recalls in the recent past, lack of clinical evidence, healthcare cost-cutting among emerging economies, and medical device excise tax in several countries.
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/855973
The report categorizes the global market for central vascular access devices into peripherally inserted central catheter (PICC), tunneled, non-tunneled, hemodialysis catheters, and Huber needles. It observes that peripherally inserted central vascular access devices have increasingly replaced traditional, surgically placed central catheters. At the subcategory level, the report examines E.G antimicrobial v/s non-antimicrobial and acute v/s chronic hemodialysis catheters. It also highlights the trends as well as the factors impacting the utilization, volume, and value of central access devices at a country level. The countries that are covered in this report are: the U.S., the U.K., France, Germany, Italy, Spain, Japan, China, India, and Brazil.
Some of the key players in the global central vascular access devices market are: AngioDynamics, Argon Medical Devices, B.Braun, C.R Bard, Edwards, Gambro, Cook Medical, Covidien, Medcomp, Teleflex, Navilyst, Perouse Medical, Smiths Medical, and Vygon. Other prominent names in this market include Becton Dickson, Melson Medical Corporation, Lepu Medical, Sungwon Medical, Wujang Evergreen, Henan Concerone Industry, and Nanjing Mayeet Import.
To order report Call Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org